- Motley Fool•4 hours ago
Inovio had a setback with its cervical dysplasia vaccine program, but the biotech also had a huge win this year.
- Investopedia•2 days ago
Inovio’s lead to develop MERS vaccine was bolstered by new funding from the International Vaccine Institute.
- GlobeNewswire•3 days ago
PLYMOUTH MEETING, Pa., Dec. 06, 2016-- Inovio Pharmaceuticals, Inc. today announced that the International Vaccine Institute will provide new funding and support to further advance GLS-5300, Inovio’ s ...
INO : Summary for Inovio Pharmaceuticals, Inc. - Yahoo Finance
Inovio Pharmaceuticals, Inc. (INO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||6.90 x 1000|
|Ask||7.25 x 900|
|Day's Range||7.10 - 7.38|
|52 Week Range||4.50 - 11.69|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-7.93|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|